ARMP: Armata Pharmaceuticals Inc
ARMP exchange rate has changed by 1.41% for today. During the day, the instrument was traded at a low of 6.16 and at a high of 6.51.
Follow Armata Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ARMP News
- Armata to advance bacteriophage therapy to phase 3 for S. aureus
- Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating
- Armata Pharma earnings missed by $0.24, revenue fell short of estimates
- Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates
- Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates
- Armata Pharmaceuticals commissions phage manufacturing facility
- Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates
- Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates
- Microsoft, Meta Set To Report Earnings As Investors Watch Out for Trump-Xi, Fed Meeting
- Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains?
- Why LendingClub Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - ReAlpha Tech (NASDAQ:AIRE), Amazon.com (NASDAQ:AMZN)
- Here’s Why Armata Pharmaceuticals Stock (ARMP) Exploded 300% Today - TipRanks.com
- Armata stock soars after positive Phase 2a bacteriophage trial results
- Armata’s bacteriophage therapy shows promise in S. aureus study
- Are Medical Stocks Lagging Armata Pharmaceuticals (ARMP) This Year?
- Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year?
- Armata pharmaceuticals announces phage structure research in JMB
- Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?
- All You Need to Know About Armata Pharmaceuticals (ARMP) Rating Upgrade to Buy
- Is Armata Pharmaceuticals (ARMP) Outperforming Other Medical Stocks This Year?
- Armata Pharma earnings missed by $0.06, revenue topped estimates
- Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Beats Revenue Estimates
- Innoviva: A Riddle Wrapped In A Mystery Inside An Enigma (NASDAQ:INVA)
- Armata stock price target raised to $9 at H.C. Wainwright
Frequently Asked Questions
What is ARMP stock price today?
Armata Pharmaceuticals Inc stock is priced at 6.47 today. It trades within 6.16 - 6.51, yesterday's close was 6.38, and trading volume reached 98. The live price chart of ARMP shows these updates.
Does Armata Pharmaceuticals Inc stock pay dividends?
Armata Pharmaceuticals Inc is currently valued at 6.47. Dividend policy depends on the company, while investors also watch 225.13% and USD. View the chart live to track ARMP movements.
How to buy ARMP stock?
You can buy Armata Pharmaceuticals Inc shares at the current price of 6.47. Orders are usually placed near 6.47 or 6.77, while 98 and 1.89% show market activity. Follow ARMP updates on the live chart today.
How to invest into ARMP stock?
Investing in Armata Pharmaceuticals Inc involves considering the yearly range 0.90 - 16.34 and current price 6.47. Many compare -0.15% and 154.72% before placing orders at 6.47 or 6.77. Explore the ARMP price chart live with daily changes.
What are Armata Pharmaceuticals Inc stock highest prices?
The highest price of Armata Pharmaceuticals Inc in the past year was 16.34. Within 0.90 - 16.34, the stock fluctuated notably, and comparing with 6.38 helps spot resistance levels. Track Armata Pharmaceuticals Inc performance using the live chart.
What are Armata Pharmaceuticals Inc stock lowest prices?
The lowest price of Armata Pharmaceuticals Inc (ARMP) over the year was 0.90. Comparing it with the current 6.47 and 0.90 - 16.34 shows potential long-term entry points. Watch ARMP moves on the chart live for more details.
When did ARMP stock split?
Armata Pharmaceuticals Inc has gone through stock splits historically. These changes are visible in , 6.38, and 225.13% after corporate actions.
- Previous Close
- 6.38
- Open
- 6.35
- Bid
- 6.47
- Ask
- 6.77
- Low
- 6.16
- High
- 6.51
- Volume
- 98
- Daily Change
- 1.41%
- Month Change
- -0.15%
- 6 Months Change
- 154.72%
- Year Change
- 225.13%
- Act
- Fcst
- Prev